USFDA clears Aurobindo’s North Carolina plant, warns another unit
The US Food and Drug Administration has issued a Voluntary Action Indicated (VAI) classification to Aurobindo Pharma's subsidiary Aurolife Pharma's plant in Raleigh, North Carolina, the company said on Monday. The VAI…
